Transcriptional response of Acinetobacter baumannii to tigecycline
Corresponding Organization : ARC Centre of Excellence in Synthetic Biology
Other organizations : University of Newcastle Australia
Variable analysis
- Tigecycline (Sigma-Aldrich, United States) treatment at 2.5 μg/ml
- Transcriptional coverage for each gene in Acinetobacter baumannii AB0057 genome
- Acinetobacter baumannii 6772166 Muller-Hinton (Oxoid, United States) broth cultures at OD600 0.6 without tigecycline treatment
- Positive control: Acinetobacter baumannii 6772166 Muller-Hinton (Oxoid, United States) broth cultures at OD600 0.6 without tigecycline treatment
- Negative control: Not explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!